首页> 美国卫生研究院文献>World Journal of Gastroenterology >Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes
【2h】

Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes

机译:制备主要用于肽的组织相容性复合体四聚体以直接定量抗原特异性细胞毒性T淋巴细胞的程序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To establish a simplified method for generating peptide-major histocompatibility complex (MHC) class I tetramers.METHODS: cDNAs encoding the extracellular domain of human lymphocyte antigen (HLA)-A*0201 heavy chain (A2) and β2-microglobulin (β2m) from total RNA extracted from leukocytes of HLA-A2+ donors were cloned into separate expression vectors by reverse transcription-polymerase chain reaction. The recombinant A2 and β2m proteins were expressed in Escherichia coli strain BL21(DE3) and recovered from the inclusion body fraction. Soluble A2 proteins loaded with specific antigen peptides were refolded by dilution from the heavy chain in the presence of light chain β2m and HLA-A2-restricted peptide antigens. The refolded A2 monomers were biotinylated with a commercial biotinylation enzyme (BirA) and purified by low pressure anion exchange chromatography on a Q-Sepharose (fast flow) column. The tetramers were then formed by mixing A2 monomers with streptavidin-PE in a molar ratio of 4:1. Flow cytometry was used to confirm the expected tetramer staining of CD8+ T cells.RESULTS: Recombinant genes for HLA-A*0201 heavy chain (A2) fused to a BirA substrate peptide (A2-BSP) and mature β2m from HLA-A2+ donor leukocytes were successfully cloned and highly expressed in E. coli. Two soluble monomeric A2-peptide complexes were reconstituted from A2-BSP in the presence of β2m and peptides loaded with either human cytomegalovirus pp65495-503 peptide (NLVPMVATV, NLV; designated as A2-NLV) or influenza virus matrix protein Mp58–66 peptide (GILGFVFTL, GIL; designated as A2-GIL). Refolded A2-NLV or A2-GIL monomers were biotinylated and highly purified by single step anion exchange column chromatography. The tetramers were then formed by mixing the biotinylated A2-NLV or A2-GIL monomers with streptavidin-PE, leading to more than 80% multiplication as revealed by SDS-PAGE under non-reducing, unboiled conditions. Flow cytometry revealed that these tetramers could specifically bind to CD8+ T cells from a HLA-A2+ donor, but failed to bind to those from a HLA-A2- donor.CONCLUSION: The procedure is simple and efficient for generating peptide-MHC tetramers.
机译:目的:建立简化的生成主要肽类组织相容性复合物(MHC)I类四聚体的方法。方法:编码人淋巴细胞抗原(HLA)-A * 0201重链(A2)和β2-微球蛋白(β2m)的胞外域的cDNA )通过逆转录-聚合酶链反应将HLA-A2 + 供体白细胞提取的总RNA克隆到单独的表达载体中。重组A2和β2m蛋白在大肠杆菌BL21(DE3)菌株中表达,并从包涵体部分回收。通过在轻链β2m和HLA-A2限制性肽抗原的存在下,从重链上进行稀释,将载有特定抗原肽的可溶性A2蛋白重折叠。将重折叠的A2单体用市售的生物素化酶(BirA)进行生物素化,并通过Q-Sepharose(快速流动)柱上的低压阴离子交换色谱法纯化。然后通过将A2单体与链霉亲和素-PE以4:1的摩尔比混合来形成四聚体。结果:将HLA-A * 0201重链(A2)的重组基因融合到BirA底物肽(A2-BSP)上,并与CD8 + T细胞进行了预期的四聚体染色。成功克隆了来自HLA-A2 + 供体白细胞的成熟β2m,并在大肠杆菌中高表达。在存在β2m的情况下,从A2-BSP重构了两个可溶性单体A2-肽复合物,并且载有人类巨细胞病毒pp65495-503肽(NLVPMVATV,NLV;命名为A2-NLV)或流感病毒基质蛋白Mp58-66肽( GILGFVFTL,GIL;指定为A2-GIL)。重折叠的A2-NLV或A2-GIL单体经过生物素化处理,并通过一步阴离子交换柱色谱进行了高度纯化。然后,通过将生物素化的A2-NLV或A2-GIL单体与链霉亲和素-PE混合,形成四聚体,导致SDS-PAGE在非还原,未煮沸条件下的增殖超过80%。流式细胞仪显示这些四聚体可以与HLA-A2 + 供体的CD8 + T细胞特异性结合,但不能与HLA-A2 的CD8 + T细胞结合。结论:该程序简单,有效,可生成肽-MHC四聚体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号